We repeated this experiment and could confirm the in silico data in vitro also, in that application of 17-β-estradiol to ERα-positive MCF7 breast cancer cells repressed Mb expression dose dependently (Figure 2B). This evidence concerns the gene ESR1 and breast carcinoma.